2.05
-0.05(-2.38%)
Currency In USD
Address
17383 Sunset Boulevard
Pacific Palisades, CA 90272
United States of America
Phone
424 473 8055
Website
Sector
Healthcare
Industry
Biotechnology
Employees
53
First IPO Date
February 16, 2018
| Name | Title | Pay | Year Born |
| Dr. David J. Lennon Ph.D. | President, Chief Executive Officer & Director | 654,400 | 1971 |
| Mr. Bryan Ball | Chief Technical Operations Officer | 460,173 | 1971 |
| Mr. Scott M. Giacobello CPA | Chief Financial Officer, Treasurer, Investor Relations & Corporate Communications | 483,407 | 1970 |
| Dr. Neil P. Desai Ph.D. | Founder & Director | 1.66M | 1965 |
| Mr. Stephen M. Rodin J.D. | Senior Vice President of Legal & General Counsel | 0 | 1976 |
| Dr. David Dornan Ph.D. | Chief Scientific Officer | 0 | 1978 |
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.